Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose “IVIG-SN” Therapy for Pediatric Patients with Kawasaki Disease

BACKGROUND AND OBJECTIVES: Intravenous immunoglobulin-SN (IVIG-SN) is a new human immunoglobulin product. Its safety is ensured by pathogen-elimination steps comprising solvent/detergent treatment and a nanofiltration process. This multicenter clinical study was designed to evaluate the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Kyung Lim, Lee, Hae Yong, Yu, Jeong Jin, Lee, Jae Young, Han, Mi Young, Kim, Ki Yong, Huh, June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378027/
https://www.ncbi.nlm.nih.gov/pubmed/28382076
http://dx.doi.org/10.4070/kcj.2016.0139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378027/
https://www.ncbi.nlm.nih.gov/pubmed/28382076
http://dx.doi.org/10.4070/kcj.2016.0139

Ejemplares similares